ID
29656
Description
Study ID: 104385 Clinical Study ID: RES104385 Study Title: A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00318630 https://clinicaltrials.gov/ct2/show/NCT00318630 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Rosiglitazone XR,Avandia XR,Avandia Study Indication: Asthma This ODM-file contains Pharmacodynamics. Time: Treatment period 1, Day 14. Part 1: Blood and AMP Challenge
Lien
https://clinicaltrials.gov/ct2/show/NCT00318630
Mots-clés
Versions (1)
- 10/04/2018 10/04/2018 - Sarah Riepenhausen
Détendeur de droits
GlaxoSmithKline
Téléchargé le
10 avril 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
GSK Influence of PPAR gamma agonist vs. Placebo on allergen-induced late asthmatic response NCT00318630
Pharmacodynamics - Treatment period 1, Day 14, Part 1
- StudyEvent: ODM
Description
Pulmonary function tests: Pre-AMP Challenge
Alias
- UMLS CUI-1
- C0024119
- UMLS CUI-2
- C1096479
- UMLS CUI-3
- C3812758
Description
pre-AMP pulmonary function test date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0024119
- UMLS CUI [1,3]
- C1096479
- UMLS CUI [1,4]
- C3812758
Description
Time relative to start of challenge. 3 pre-saline measurements are required.
Type de données
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0748133
Description
Time of FEV1
Type de données
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0429706
Description
FEV1 Reading
Type de données
float
Unités de mesure
- L
Alias
- UMLS CUI [1,1]
- C0456984
- UMLS CUI [1,2]
- C0429706
Description
Pulmonary function tests: AMP Challenge
Alias
- UMLS CUI-1
- C0024119
- UMLS CUI-2
- C1096479
Description
AMP-Challenge Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1096479
Description
Inhaled Substance
Type de données
text
Alias
- UMLS CUI [1,1]
- C0205535
- UMLS CUI [1,2]
- C0001465
- UMLS CUI [2,1]
- C0205535
- UMLS CUI [2,2]
- C0036082
Description
Following the baseline assessment in which FEV1 is measured after inhalation of saline, subjects are to inhale doubling increments of AMP until a ≥20percent fall in FEV1 from the baseline saline value is achieved. 0.000 is the concentration value for saline.
Type de données
text
Unités de mesure
- mg/mL
Alias
- UMLS CUI [1,1]
- C1446561
- UMLS CUI [1,2]
- C0001465
Description
Fill in only for saline inhalation.
Type de données
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0001559
Description
Stop Time of Inhalation
Type de données
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C0001559
Description
Both timepoints must be filled after each inhalation. Time relative to stop time of inhalation.
Type de données
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0205535
- UMLS CUI [1,3]
- C0748133
Description
Pulmonary function time
Type de données
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0429706
Description
FEV1 Result
Type de données
float
Unités de mesure
- L
Alias
- UMLS CUI [1,1]
- C0429706
- UMLS CUI [1,2]
- C1096479
Description
Pulmonary function tests: Post-AMP Challenge
Alias
- UMLS CUI-1
- C0231921
- UMLS CUI-2
- C1096479
- UMLS CUI-3
- C0439568
Description
Date of post-challenge FEV1
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0429706
- UMLS CUI [1,3]
- C0439568
Description
Time relative to end of challenge: Post-challenge 6 measurements are required.
Type de données
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0429706
- UMLS CUI [1,3]
- C0439568
Description
Record use of rescue Salbutamol on the Concomitant Medications page.
Type de données
float
Unités de mesure
- L
Alias
- UMLS CUI [1,1]
- C0429706
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C0439568
Similar models
Pharmacodynamics - Treatment period 1, Day 14, Part 1
- StudyEvent: ODM
C1277698 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C1096479 (UMLS CUI-2)
C3812758 (UMLS CUI-3)
C0024119 (UMLS CUI [1,2])
C1096479 (UMLS CUI [1,3])
C3812758 (UMLS CUI [1,4])
C0748133 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C0429706 (UMLS CUI [1,2])
C1096479 (UMLS CUI-2)
C1096479 (UMLS CUI [1,2])
C0001465 (UMLS CUI [1,2])
C0205535 (UMLS CUI [2,1])
C0036082 (UMLS CUI [2,2])
C0001465 (UMLS CUI [1,2])
C0001559 (UMLS CUI [1,2])
C0001559 (UMLS CUI [1,2])
C0205535 (UMLS CUI [1,2])
C0748133 (UMLS CUI [1,3])
C0429706 (UMLS CUI [1,2])
C1096479 (UMLS CUI [1,2])
C1096479 (UMLS CUI-2)
C0439568 (UMLS CUI-3)
C0429706 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0429706 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])